Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

AFG3L2-related optic atrophy and/or spastic ataxia spectrum

MONDO:0700372

Any disorder caused by a heterozygous variant or biallelic variants in the AFG3L2 gene and characterized by a spectrum of phenotypes including optic atrophy and/or spastic ataxia.

Also known as: AFG3L2-related optic atrophy and/or spastic ataxia spectrum

13 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Optic atrophy 12 (0) Spastic ataxia 5 (0)

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Inborn mitochondrial metabolism disorder (58) Inborn errors of metabolism (45) Mitochondrial disease (40) Human disease (14) Developmental defect during embryogenesis (8) Mitochondrial DNA depletion syndrome (3) Mitochondrial oxidative phosphorylation disorder (3)
Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 4 Completed 2 Terminated 1
Sort by
  • New DNA test could end years of uncertainty for mitochondrial disease patients

    Diagnosis Not yet recruiting

    This pilot study aims to develop a new digital PCR technique to more accurately diagnose mitochondrial diseases. Researchers will test the method on blood, urine, saliva, and muscle fiber samples from 4 patients. If validated, the technique could be faster and cheaper than curren…

    Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis

    Last updated Jun 27, 2026 12:04 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space